Skip to main content
. 2017 Aug 29;7:9686. doi: 10.1038/s41598-017-09671-7

Figure 5.

Figure 5

IL-6, TNFα and RANKL expression decreased in gastric mucosa of patient2 and patient3 after them receiving celecoxib treatment. P2, patient2; P3, patient3. (a,d,g and j) showed immunohistochemical staining of IL-6. (b,e,h and k) showed immunohistochemical staining of TNFα. (c,f,i and l) showed immunohhistochemical staining of RANKL. Patient2 and patient3 received celecoxib treatment for three months. IL-6, TNFα and RANKL expression in their gastric mucosa decreased after the treatment (df, jl). Immunostained specimens were assessed by pathologists blinding to clinical features.